
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
ImaginAb is a clinical stage, revenue-generating global biotechnology company developing the next generation of imaging agents and radiopharmaceutical therapy (RPT) products through its proprietary minibody and cys-diabody platforms. The lead candidate 89Zr crefmirlimab berdoxam (CD8 ImmunoPETTM) imaging agent is currently in Phase II clinical trials and has been licensed by numerous pharmaceutical and biotech companies for use in imaging within their immunotherapy clinical trials, primarily in oncology
Antibody engineering and imaging,personalized medicine,therapeutic management,clinical development,pet radiopharmaceuticals,89zr-,pet imaging,minibody,biomarker,immunocology,cd8,t cells,immunology,oncology,cancer,and cd8 tracer
Imaginab operates in the Biotechnology research industry.
Imaginab's revenue is 11m - 100m
Imaginab has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.